Baystreet Staff - Monday, July 11, 2016 Kite Pharma (KITE) Down on BioLife Deal Kite Pharma Inc. (NASDAQ: KITE) shares retreated 0.6% to $48.22, as the company announced a 10-year supply contract with BioLife Solutions. Share volume was 405,000, compared to an all-day average of 836,000